CYP1A2 phenotyping in dried blood spots and microvolumes of whole blood and plasma

Bioanalysis

Volumn 6, Issue 22, 2014, Pages 3011-3024

  De Kesel, Pieter M M ^a   Lambert, Willy E ^a   Stove, Christophe P ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CYTOCHROME P450 1A2; PARAXANTHINE; 1,7-DIMETHYLXANTHINE; THEOPHYLLINE;

ADULT; ARTICLE; BLOOD SAMPLING; BLOOD VOLUME; CALIBRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRIED BLOOD SPOT TESTING; FEMALE; HEMATOCRIT; HUMAN; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; NORMAL HUMAN; PHENOTYPE; PLASMA VOLUME; PRODUCT RECOVERY; SENSITIVITY ANALYSIS; VALIDATION PROCESS; BLOOD; ENZYMOLOGY; PLASMA; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY;

CAFFEINE; CHROMATOGRAPHY, LIQUID; CYTOCHROME P-450 CYP1A2; HUMANS; PLASMA; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; THEOPHYLLINE;

EID: 84918525612     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.14.149     Document Type: Article

References (39)

1. Wilkinson GR. Drug metabolism and variability among patients in Drug response N. Eng. J. Med. 352 21 2211-2221 2005
2. Zanger U.M. Schwab M. Cytochrome P450 enzymes in Drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol. Ther. 138(1) 103-141 2013
3. Zanger U.M. Klein K. Thomas M., et al. Genetics, epigenetics, and regulation of drug-metabolizing cytochrome p450 enzymes. Clin. Pharmacol. Ther. 95(3) 258- 261 2014
4. Tantcheva-Poor I, Zaigler M, Rietbrock S, Fuhr U. Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics 9(2), 131-144 (1999
5. Lampe JW, King IB, Li S et al. Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets. Carcinogenesis 21(6), 1157-1162 (2000
6. Yoshinari K, Ueda R, Kusano K, Yoshimura T, Nagata K, Yamazoe Y. Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements. Biochem. Pharmacol. 76(1), 139-145 (2008
7. Magnusson MO, Dahl ml, Cederberg J, Karlsson MO, Sandström R. Pharmacodynamics of carbamazepine-mediated induction of CYP3A4, CYP1A2, and Pgp as assessed by probe substrates midazolam, caffeine, and digoxin. Clin. Pharmacol. Ther. 84(1), 52-62 (2008
8. Karjalainen MJ, Neuvonen PJ, Backman JT. In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions. Basic Clin. Pharmacol. 103(2), 157-165 (2008
9. Arranz MJ, de Leon J. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research. Mol. Psychiatry 12(8), 707-747 (2007
10. Rajkumar AP, Poonkuzhali B, Kuruvilla A, Jacob M, Jacob KS. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia. Int. Clin. Psychopharm. 28(1), 50-56 (2013
11. Fuhr U, Jetter A, Kirchheiner J. Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach. Clin. Pharmacol. Ther. 81(2), 270-283 (2007
12. Kalow W, Tang BK. The use of caffeine for enzyme assays - A critical appraisal. Clin. Pharmacol. Ther. 53(5), 503-514 (1993
13. Perera V, Gross AS, McLachlan AJ. Measurement of CYP1A2 activity: a focus on caffeine as a probe. Curr. Drug Metab. 13(5), 667-678 (2012
14. Bowen CL, Hemberger MD, Kehler JR, Evans CA. Utility of dried blood spot sampling and storage for increased stability of photosensitive compounds. Bioanalysis 2(11), 1823-1828 (2010
15. Bowen CL, Volpatti J, Cades J, Licea-Perez H, Evans CA. Evaluation of glucuronide metabolite stability in Dried blood spots. Bioanalysis 4(23), 2823-2832 (2012
16. D'Arienzo CJ, Ji QC, Discenza L et al. DBS sampling can be used to stabilize prodrugs in Drug discovery rodent studies without the addition of esterase inhibitors. Bioanalysis 2(8), 1415-1422 (2010
17. Faller A, Richter B, Kluge M, Koenig P, Seitz HK, Skopp G. Stability of phosphatidylethanol species in spiked and authentic whole blood and matching dried blood spots. Int. J. Legal Med. 127(3), 603-610 (2013
18. Ingels AS, Hertegonne K, Lambert W, Stove CP. Feasibility of following up gamma-hydroxybutyric acid concentrations in sodium oxybate (Xyrem')-Treated narcoleptic patients using dried blood spot sampling at home: an exploratory study. CNS Drugs 27, 233-237 (2013
19. Ooms JA, Knegt L, Koster EH. Exploration of a new concept for automated dried blood spot analysis using flow-Through desorption and online SPE-MS/MS. Bioanalysis 3(20), 2311-2320 (2011
20. Déglon J, Thomas A, Mangin P, Staub C. Direct analysis of dried blood spots coupled with mass spectrometry: concepts and biomedical applications. Anal. Bioanal. Chem. 402(8), 2485-2498 (2012
21. Edelbroek PM, van Der Heijden J, Stolk LM. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls. Ther. Drug Monit. 31(3), 327-336 (2009
22. Stove CP, Ingels AS, De Kesel PM, Lambert WE. Dried blood spots in toxicology: from the cradle to the grave?. Crit. Rev. Toxicol. 42(3), 230-243 (2012
23. de Boer T, Wieling J, Meulman E et al. Application of dried blood spot sampling combined with LC-MS/MS for genotyping and phenotyping of CYP450 enzymes in healthy volunteers. Biomed. Chromatogr. 25(10), 1112- 1123 (2011
24. Déglon J, Thomas A, Daali Y et al. Automated system for on-line desorption of dried blood spots applied to LC/MS/MS pharmacokinetic study of flurbiprofen and its metabolite. J. Pharm. Biomed. Anal. 54(2), 359-367 (2011
25. Daali Y, Samer C, Déglon J et al. Oral flurbiprofen metabolic ratio assessment using a single-point dried blood spot. Clin. Pharmacol. Ther. 91(3), 489-496 (2012
26. Donzelli M, Derungs A, Serratore MG et al. The basel cocktail for simultaneous phenotyping of human cytochrome p450 isoforms in plasma, saliva and dried blood spots. Clin. Pharmacokinet. 53(3), 271-282 (2014
27. Bosilkovska M, Deglon J, Samer C et al. Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasma. Bioanalysis 6(2), 151-164 (2014
28. European Medicines Agency. Guideline on bioanalytical method validation. www.ema.europa.eu/docs/en-GB/document-library/ Scientific-guideline/2011/08/WC500109686.pdf
29. US Department of Health and Human Services. Food and Drug Administration. Center for Drug Evaluation and Research. Center for Veterinary Medicine. Draft Guidance for Industry. Bioanalytical Method Validation (2013).www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm368107.pdf
30. De Kesel PM, Sadones N, Capiau S, Lambert WE, Stove CP. Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions. Bioanalysis 5(16), 2023-2041 (2013
31. Capiau S, Stove VV, Lambert WE, Stove CP. Prediction of the hematocrit of dried blood spots via potassium measurement on a routine clinical chemistry analyzer. Anal. Chem. 85(1), 404-410 (2013
32. Almeida AM, Castel-Branco mm, Falcao AC. Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 774(2), 215-222 (2002
33. Wille SMR, Peters FT, Di Fazio V, Samyn N. Practical aspects concerning validation and quality control for forensic and clinical bioanalytical quantitative methods. Accred. Qual. Assur. 16(6), 279-292 (2011
34. Matuszewski BK, Constanzer ml, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 75(13), 3019-3030 (2003
35. Denniff P, Spooner N. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs. Bioanalysis 2(8), 1385-1395 (2010
36. Rowland M, Emmons GT. Use of dried blood spots in Drug development: pharmacokinetic considerations. AAPS J. 12(3), 290-293 (2010
37. Rainey PM. Relation between serum and whole-blood ethanol concentrations. Clin. Chem. 39(11), 2288-2292 (1993
38. Youhnovski N, Bergeron A, Furtado M, Garofolo F. Pre-cut dried blood spot (PCDBS): an alternative to dried blood spot (DBS) technique to overcome hematocrit impact. Rapid Commun. Mass Spectrom. 25(19), 2951-2958 (2011
39. De Kesel PM, Lambert WE, Stove CP. Why dried blood spots are an ideal tool for CYP1A2 phenotyping. Clin. Pharmacokinet. 53(8), 763-771 (2014